What Are the Therapeutic Strategies for Managing Reduced UGT Activity?
Managing reduced UGT activity requires a personalized approach. For individuals with genetic polymorphisms, dose adjustments or alternative medications that do not rely on glucuronidation may be necessary. In cases of liver disease, addressing the underlying condition can help restore UGT activity. Furthermore, healthcare providers should monitor patients closely for signs of toxicity and adjust treatment regimens accordingly.
